Trial
NCT02920996
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Eli Lilly and Company
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
Merestinib
Why stopped
Funding was pulled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-11